Genesys International Corporation Ltd (GENESYS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Genesys International Corporation Ltd on NSE and BSE, with an AI summary of each filing.
Genesys International Corporation Limited has informed the exchange regarding Scrutinizer''s Report and Voting Results of the 44th Annual General Meeting held on September 30, 2026
Annual General Meeting · 01 Oct 2026, 9:51 pm
Proceedings of the 44th Annual General Meeting of the Company held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 11:27 pm
Genesys International Corporation Limited has informed the exchange regarding - Genesys International wins contract valued at INR 283 crore for Ahmedabad''s 3D Digital Twin and Spatial ....
Others (Uncategorized) · 24 Sept 2026, 10:32 pm
Genesys International Wins ₹283 Crore World Bank-Funded Ahmedabad Digital Twin Contract Genesys International secured a ₹283 crore (inclusive of taxes) World Bank-funded contract from Ahmedabad Municipal Corporation to develop a GIS 3D digital map platform. Spanning ~625 sq. km, the project entails surveying, geocoding, and assigning unique digital IDs to ~25 lakh properties, while mapping critical civic assets including roads, water networks, sewerage, and drainage infrastructure. The contract has an execution timeline of 2.5 years, strengthening the company's geospatial order book with no promoter interest or related-party involvement.
Pursuant to Regulations 36(1)(b) of the SEBI Listing Regulations, the Company has sent a letter providing a web-link of the annual report 2025-26 to those Members who have not registered ....
Annual Report · 05 Sept 2026, 1:07 am
In terms of provision of Regulation 34(2)(f) of Securities Exchange Board of India (Listing Obligation Disclosure Requirements) Regulations, 2015, we are enclosing Business Responsibility ....
Others (Uncategorized) · 05 Sept 2026, 1:00 am
In terms of provision of Regulation 34(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the 44th Annual Report ....
Others (Uncategorized) · 05 Sept 2026, 12:49 am
Notice of 44th Annual General Meeting of the company shall be held on Wednesday 30th September, 2026 through Video Conferencing and Audio Visual Means
Annual General Meeting · 05 Sept 2026, 12:39 am
Genesys International Corporation Limited has informed the Exchange regarding - Grant of stock options under ("Genesys ESOP Scheme - 2022)
Others (Uncategorized) · 03 Sept 2026, 1:13 am
Genesys International Approves 2026 ESOP Scheme and Key Auditor Changes Genesys International's board approved the "Genesys ESOP Scheme 2026", proposing up to 30,00,000 stock options. Additionally, the board granted 1,82,640 additional options under the 2022 ESOP scheme at an exercise price of ₹50 to adjust for a recent rights issue. On the governance front, G.K. Choksi & Co. will replace MSKA & Associates as Statutory Auditor for a 5-year term, while XAG & Co. was appointed Internal Auditor for FY26-27 following H.C. Vora & Associates' resignation. The 44th AGM is scheduled for 30th Sep'26.
Genesys International Corporation Limited has informed the Exchange regarding - Appointment of Statutory Auditor of the Company
Change in Management · 03 Sept 2026, 12:58 am
Genesys International Board Approves 2026 ESOP Scheme and Auditor Changes Genesys International’s board approved the 2026 ESOP Scheme, authorizing up to 30 lakh options. Additionally, adjusting for a recent rights issue, the board granted 1,82,640 additional options under the 2022 ESOP at a ₹50 exercise price. Management also overhauled its audit framework, appointing G.K. Choksi & Co. as Statutory Auditors for a five-year term and XAG & Co. as Internal Auditors effective 2nd Sep'26, following the resignations of prior auditors. The company’s 44th AGM will convene on 30th Sep'26.
Genesys International Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026.
Outcome · 03 Sept 2026, 12:57 am
Genesys International Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026
Outcome · 03 Sept 2026, 12:52 am
Genesys International Approves 30 Lakh ESOPs and Restructures Auditor Appointments Genesys International's board approved the new ESOP Scheme 2026 on 2nd Sep'26, authorizing up to 30 lakh stock options. To account for a recent rights issue, the board also adjusted the ESOP 2022 scheme, granting 1,82,640 supplementary options at a ₹50 exercise price. Governance updates include appointing G.K. Choksi & Co. as Statutory Auditors for five years, replacing MSKA & Associates, and naming XAG & Co. as Internal Auditors for FY27 following a resignation. The company's 44th AGM will be held on 30th Sep'26.
Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve the Genesys ....
Intimation · 29 Aug 2026, 12:08 am
Genesys Board to Consider New Employee Stock Option Scheme Genesys International Corporation has scheduled a Board of Directors meeting on 02 Sep'26. The primary agenda is to consider and approve the "Genesys Employee Stock Option Scheme - 2026". The implementation of this new ESOS will be subject to subsequent approval from the company's shareholders.
Required Clarification is attached
Others (Uncategorized) · 28 Aug 2026, 5:02 pm
The Exchange has sought clarification from Genesys International Corporation Ltd on August 27, 2026 with reference to significant movement in price, in order to ensure that investors have ....
Others (Uncategorized) · 27 Aug 2026, 10:36 pm
Please find attached press release titled "Genesys International appoints Dhiman Basu Ray as Chief Technology Officer"
Press Release · 27 Aug 2026, 4:11 pm
Genesys Appoints New CTO to Drive AI-Powered Spatial Intelligence Strategy Genesys International announced the appointment of Dhiman Basu Ray as its new Chief Technology Officer on 27 Aug'26. Ray, formerly the Global CTO for Digital Engineering at Tech Mahindra, brings 26 years of experience in AI, robotics, and digital platforms. This key appointment signals Genesys' strategic shift from Digital Twins to building an AI-powered Spatial Intelligence layer. The company aims to leverage its geospatial data and high-precision mapping to create intelligent, scalable platforms for governments, enterprises, and emerging Physical AI applications.
Genesys International Corporation Limited informed the Exchange regarding Allotment of Equity Shares pursuant to Right Issue
Others (Uncategorized) · 25 Aug 2026, 1:59 am
Genesys International Allots Equity Shares via Rights Issue Genesys International's board approved the allotment of 2,50,74,226 equity shares on Aug 24, '26, via a rights issue. The shares have a face value of ₹5 and were issued at ₹50 per share, including a ₹45 premium. This allotment increases the company's paid-up share capital from ₹20.89 cr to ₹33.34 cr. The total number of paid-up shares now stands at 6,68,64,603. The allotment follows the terms of the Letter of Offer dated Jul 31, '26. These new shares will rank pari passu with existing equity shares.
Please find attached a copy of press release titled " Genesys International appoints Nikhil Alulkar as Chief Executive officer"
Press Release · 17 Aug 2026, 2:30 pm
Genesys International Appoints Tech Mahindra Veteran Nikhil Alulkar as New CEO Genesys International (NSE: GENESYS) appointed Nikhil Alulkar as CEO on 17 Aug'26 to lead its next growth phase. Alulkar, formerly Head of India Business & Sr. VP at Tech Mahindra, will drive expansion beyond government contracts into enterprise and B2B markets. The strategy focuses on scaling its AI-native mapping, Digital Twin, and spatial intelligence platforms in India and internationally. This move signals a shift from traditional mapping to becoming a broader spatial intelligence provider, aiming to productize its high-precision geospatial data for wider industry applications.
Monitoring Agency Report for the quarter ended June 30, 2026
Others (Uncategorized) · 15 Aug 2026, 1:57 am
Genesys QIP Fund Use Scrutinized; Delays & Negative Indicators Noted CARE Ratings' Q1FY27 report for Genesys flags deviations in the use of its Rs. 110 crore QIP proceeds. The firm temporarily diverted Rs. 17.38 crore for unapproved purposes, breaching interim use terms, despite returning the funds. Significant project delays persist, with Rs. 75.16 crore unutilized as of 30-Jun'26. The implementation timeline for Rs. 75.29 crore has been extended to 31-Mar'27. Other negative factors include a 50% share price decline in the last year and promoter pledge increasing to 16% from 9.01% QoQ.
Appointment of Mr. Nikhil Alulkar as Chief Executive Officer and Key Managerial Personnel, Re-designation of Mr. Aniruddha Roy as Chief Innovation Officer and Appointment of Mr. Dhiman ....
Change in Management · 15 Aug 2026, 1:39 am
Genesys Announces Major Leadership Reshuffle; Appoints New CEO, CIO, and CTO Genesys International's board has approved significant leadership changes effective 14 Aug'26. Mr. Nikhil Alulkar, with over 25 years of experience from Tech Mahindra, Microsoft, and SAP, is appointed as the new CEO. Incumbent CTO Dr. Aniruddha Roy has been re-designated as Chief Innovation Officer. Mr. Dhiman Ray, a veteran from Tech Mahindra and TCS with 26 years of experience, will take over as the new CTO. The company also approved its unaudited financial results for the quarter ended 30 Jun'26.
Board of Directors of the Company, at their meeting held on today i.e. Friday, August 14, 2026 have inter alia considered and approved the following: Unaudited Financial Results (Standalone ....
Outcome · 15 Aug 2026, 1:35 am
Genesys Announces Management Reshuffle and Q1'FY27 Financial Results Genesys reported for Q1'FY27 (ended Jun 30, '26) a consolidated net profit of ₹5.3 Cr, down 25% YoY and 57% QoQ. Consolidated revenue from operations was ₹81.4 Cr, up 15% YoY but down 22% QoQ. The board appointed Mr. Nikhil Alulkar as CEO and Mr. Dhiman Ray as CTO, effective Aug 14, '26. Existing CTO Mr. Aniruddha Roy was re-designated as Chief Innovation Officer. The company is also proceeding with a rights issue opening Aug 14, '26 to raise approx. ₹125 Cr.
Financial Results for the quarter ended June 30, 2026
Financial Result · 15 Aug 2026, 1:31 am
Genesys International Corporation Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 8,136 (+14.8% YoY | -21.9% QoQ) ■ EBITDA: 2,813 (-4.6% YoY | -17.5% QoQ) ■ EBITDA Margin (%): 34.6 (-705 bps YoY | +185 bps QoQ) ■ PAT: 533 (-25.1% YoY | -56.9% QoQ) ■ EPS (INR): 1.26 (-27.6% YoY | -58.6% QoQ)
Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the un-audited ....
Intimation · 14 Aug 2026, 5:30 am
Genesys International Board Meeting Set for Aug'26 to Approve Q1 Results Genesys International Corporation Ltd (BSE: 506109, NSE: GENESYS) has scheduled a Board of Directors meeting on 14 Aug'26. The agenda includes the consideration and approval of the company's un-audited standalone and consolidated financial results for the first quarter ended 30 Jun'26. This meeting is a key event for tracking the company's Q1 FY27 performance.
Letter of Offer
Others (Uncategorized) · 01 Aug 2026, 12:42 am
The Rights Issue Committee meeting held today i.e July 31, 2026 fixed the record date for Rights Issue as Thursday, August 06, 2026 to determine the existing equity shareholders who will ....
Rights Issue · 31 Jul 2026, 11:17 pm
Genesys International Approves Terms for ₹1,253.7 mn Rights Issue Genesys International's Rights Issue Committee approved raising up to ₹1,253.71 mn by issuing 25,074,226 equity shares. The issue price is set at ₹50 per share, including a ₹45 premium. The entitlement ratio is 3 new shares for every 5 held. The record date to determine shareholder eligibility is 06 Aug'26. The issue will open on 14 Aug'26 and close on 21 Aug'26. Following the issue, assuming full subscription, the total paid-up equity shares will increase to 66,864,603.
The meeting of Rights Issue Committee held on July 31, 2026 approved the Record date for the Rights Issue as on August 06, 2026 and at the ratio of 3 (three) rights Equity Shares for every ....
Outcome · 31 Jul 2026, 11:12 pm
Genesys International Approves Terms for ₹125.37 Crore Rights Issue Genesys International's Rights Issue Committee approved terms for its upcoming rights issue on 31 Jul'26. The company will issue 2.51 crore shares at ₹50 each, including a ₹45 premium, aiming to raise up to ₹125.37 crores. The entitlement ratio is set at 3 rights shares for every 5 shares held. The record date to determine shareholder eligibility is 06 Aug'26. The issue will open on 14 Aug'26 and close on 21 Aug'26, with on-market renunciation ending 18 Aug'26.